Compound 849
Identifiers
- Canonical SMILES:
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)N(Cc1ccccc1)C(=O)c1ccccc1
- IUPAC name:
4-[4-[benzoyl(benzyl)amino]piperidin-1-yl]-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide
- InChi:
InChI=1S/C44H48N6O6S2/c1-47(2)27-24-36(32-57-39-16-10-5-11-17-39)45-41-23-22-40(30-42(41)50(53)54)58(55,56)46-43(51)34-18-20-37(21-19-34)48-28-25-38(26-29-48)49(31-33-12-6-3-7-13-33)44(52)35-14-8-4-9-15-35/h3-23,30,36,38,45H,24-29,31-32H2,1-2H3,(H,46,51)/t36-/m1/s1
- InChiKey:
RNYUNUOURBEZGA-PSXMRANNSA-N
External links
42601679 |
External search
Bibliography (1)
Publication | Name |
---|---|
Haixiao Zhai, Xiong Cai, Curis, Inc.. . Bcl-2 inhibitors None. | 4 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 5.30 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 820.31 g/mol | |||
HBA | 12 | |||
HBD | 2 | |||
HBA + HBD | 14 | |||
AlogP | 6.39 | |||
TPSA | 147.88 | |||
RB | 16 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009036035 | 4 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 5.30 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5175 | Navitoclax | DB12340 | |
0.4591 | Sulfabenzamide | DB09355 | |
0.4450 | 3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide | DB04394 | |
0.4448 | Venetoclax | DB11581 | |
0.4365 | [4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID | DB07986 | |
0.4223 | Nelfinavir | DB00220 | |
0.4179 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4162 | (S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide | DB03950 | |
0.4162 | (R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide | DB02479 | |
0.4124 | Pipotiazine | DB01621 | |
0.4120 | 2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid | DB07691 | |
0.4099 | Repinotan | DB06506 | |
0.4036 | Saccharin | DB12418 | |
0.3981 | Amisulpride | DB06288 | |
0.3977 | Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide | DB03031 |